Acutus Medical attracts $2.5M for cardiac arrhythmia Dx development

Acutus Medical, which is developing an electrophysiology diagnostic to map cardiac arrhythmias, has raised an additional $2.5 million in an expanded Series A round meant to raise a total of $5 million. Investors include Index Ventures and Advent Venture Partners. This, as MedCity News reports, is meant to build on $5.4 million raised in January. The company will use the money to support ongoing technology development. Acutus is based in both San Diego, CA, and Zurich, Switzerland. Story

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.